Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Avatar

Neoadjuvant Therapy for Advanced Resectable Nodal Metastases: Advantages, Potential Candidates & Clinical Trials in Melanoma

By Melanoma 2019: 29th Annual Cutaneous Malignancy Update FEATURING Merrick Ross
By Melanoma 2019: 29th Annual Cutaneous Malignancy Update FEATURING Merrick Ross
643 views
February 7, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
10:39
Moffitt Cancer Center

Clinical Implications of COMBI-d and COMBI-v Trials on OS in Patient…

Feat. A. Tarhini
27:29
Total Health

2023 ASCO® Direct Philadelphia: Melanoma Updates

Feat. M. Orloff
13:55
Northwestern Medicine Oncology and Hematology

Utilization of COMBI-APlus Data in Clinical Practice: Adapted Pyrexi…

Feat. S. Chandra
25:21
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

Treatment of Advanced Melanoma in 2023

Feat. K. Bollin
24:53
OncoAlert

Recent Melanoma Updates

Feat. A. Betof Warner
16:14
Kim Margolin

Highlights From the Recent Melanoma Research Alliance Meeting: What&…

10:11
Memorial Sloan Kettering Cancer Center

2022 Updates in the Treatment of Melanoma

Feat. M. Postow
44:30
Penn Medicine Abramson Cancer Center

De-Escalating Surgery for Clinical Stage II & III Melanoma

Feat. V. Sondak
08:59
Insights from 2023 Society for Melanoma Research Annual Meeting

2023 SMR Congress Insights: "Study of DYP688, an ADC Delivering…

Feat. M. Carlino
20:08
NYU Langone

Treatment Questions for Medical Oncologists Treating Melanoma

Feat. J. Weber
26:00
International Congress on Cancer Metastasis

Neoadjuvant Therapy for Resectable Melanoma

Feat. G. Karakousis
04:19
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CheckMate 238 Trial - Adjuvant Nivo vs. Ip…

Feat. P. Ascierto
04:53
CancerGRACE

Neoadjuvant Therapy for Advanced Melanoma: Does It Give a Better Imm…

Feat. V. Sondak
30:24
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Newer Immunotherapies in the Management of Advanced Melanoma

Feat. A. Salama
46:28
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

2024 Melanoma Update: Insights Into Sentinel Node Evaluation

Feat. M. Ross
33:28
ecancer

ESMO 2022: Highlights, Commentary, and Analysis of the Key Studies

Feat. B. Gyawali